Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro.

In coronary arterial rings isolated from horses, 10(-8)-10(-6) mol/l acetylcholine (ACh) induced concentration-dependent contractions which were potentiated by the removal of endothelium and by pretreatment with L-nitro-arginine (LNAG) or methylene blue (MB). Relatively lower concentrations of ACh (10(-14)-10(-8) mol/l) induced relaxation when the coronary rings were contracted by phenylephrine (PE). ACh-induced contractions in the coronary rings without endothelium were competitively inhibited by each muscarinic subtype selective antagonist in the following order of potency: 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) > pirenzepine > or = parafluoro-hexahydrosiladiphenidol (pFHHSiD) > methoctramine. ACh-induced relaxation in the rings with endothelium was inhibited by LNAG or MB, and by each selective antagonist in the following order of potency: 4-DAMP > pFHHSiD > pirenzepine > methoctramine. These results suggest that the ACh-induced contraction and relaxation in equine coronary arteries are mediated mainly by an M3-receptor located on the smooth muscle cells and endothelial cells, respectively, and that the stimulation of the M3-receptor on the endothelial cells liberates nitric oxide.

[1]  I. Sakurai.  Coronary Artery Spasm and Vascular Biology: Cholinergic Constriction , 1991, Acta pathologica japonica.

[2]  A. Miyamoto,et al.  Participation of H1-receptors in histamine-induced contraction and relaxation of horse coronary artery in vitro. , 1991, The Journal of veterinary medical science.

[3]  K. Malik,et al.  Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. , 1991, The Journal of pharmacology and experimental therapeutics.

[4]  W. Kukovetz,et al.  Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies. , 1991, European journal of pharmacology.

[5]  R. Eglen,et al.  Heterogeneity of vascular muscarinic receptors. , 1990, Journal of autonomic pharmacology.

[6]  R. Eglen,et al.  The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro , 1990, British journal of pharmacology.

[7]  L. Ignarro.  Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.

[8]  L. Ignarro.  Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  T. Yoshihara,et al.  Cardiopathology of sudden cardiac death in the race horse. , 1987, Heart and vessels. Supplement.

[10]  U. Förstermann,et al.  Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. , 1986, European journal of pharmacology.

[11]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[12]  R. Tallarida,et al.  pA2 and receptor differentiation: a statistical analysis of competitive antagonism. , 1979, Life sciences.

[13]  R. Gerrity,et al.  Endothelial cell morphology in focal areas of in vivo Evans blue uptake in the young pig aorta. I. Quantitative light microscopic findings. , 1974, Experimental and molecular pathology.